Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

These gene variations are not linked to alopecia areata in Egyptians.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Improved diagnosis and affordable topical treatments are essential for managing alopecia areata in India.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Timely diagnosis and active treatment improve outcomes for massive pulmonary embolism.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Stem cells could improve hair growth and new treatments for baldness are being researched.

JAK inhibitors effectively treat skin conditions and topical forms are safer.